Skip to main content
. 2020 Apr 22;11:247. doi: 10.3389/fendo.2020.00247

Table 3.

Association between four significant SNPs and GDM susceptibility.

Genotype GDM cases (n = 964)
N (%)
Controls (n = 1,021) N (%) OR (95%CI) P OR (95%CI)a Pa
FTO rs1121980
   G/G 688 (72.0) 673 (66.5) 1.00 1.00
   A/G 243 (25.4) 298 (29.4) 0.80 (0.65–0.97) 0.027 0.80 (0.65–0.98) 0.028
   A/A 25 (2.6) 41 (4.1) 0.60 (0.36–0.99) 0.046 0.62 (0.37–1.04) 0.071
   Dominant 0.77 (0.64–0.94) 0.009 0.78 (0.64–0.94) 0.011
   Recessive 0.64 (0.38–1.05) 0.075 0.66 (0.40–1.11) 0.112
   Additive 0.79 (0.67–0.93) 0.005 0.79 (0.67–0.94) 0.007
KCNQ1 rs163182
   G/G 427 (45.4) 398 (39.6) 1.00 1.00
   C/G 398 (42.3) 462 (46.0) 0.80 (0.66–0.97) 0.025 0.80 (0.66–0.98) 0.028
   C/C 115 (12.2) 144 (14.3) 0.74 (0.56–0.99) 0.039 0.73 (0.55–0.97) 0.030
   Dominant 0.79 (0.66–0.94) 0.010 0.79 (0.65–0.94) 0.010
   Recessive 0.83 (0.64–1.08) 0.171 0.81 (0.62–1.06) 0.132
   Additive 0.85 (0.74–0.96) 0.011 0.84 (0.73–0.96) 0.009
MC4R rs12970134
   G/G 590 (62.4) 679 (67.0) 1.00 1.00
   A/G 300 (31.7) 300 (29.6) 1.15 (0.95–1.40) 0.157 1.13 (0.93–1.38) 0.218
   A/A 55 (5.8) 35 (3.5) 1.81 (1.17–2.80) 0.008 1.99 (1.28–3.09) 0.002
   Dominant 1.22 (1.01–1.47) 0.036 1.22 (1.01–1.47) 0.040
   Recessive 1.73 (1.12–2.67) 0.012 1.91 (1.23–2.95) 0.003
   Additive 1.23 (1.06–1.44) 0.008 1.25 (1.07–1.46) 0.006
PROX1 rs340841
   C/C 249 (26.3) 312 (31.1) 1.00 1.00
   C/T 472 (49.8) 492 (49.1) 1.20 (0.98–1.48) 0.084 1.27 (1.02–1.57) 0.030
   T/T 226 (23.9) 199 (19.8) 1.42 (1.10–1.83) 0.006 1.49 (1.15–1.92) 0.003
   Dominant 1.27 (1.04–1.54) 0.019 1.33 (1.09–1.63) 0.005
   Recessive 1.27 (1.02–1.57) 0.031 1.28 (1.03–1.59) 0.028
   Additive 1.19 (1.05–1.35) 0.006 1.22 (1.07–1.39) 0.002
a

Logistic regression analyses adjusted for age, pre-pregnancy BMI, parity, abnormal pregnancy history, and family history of diabetes. GDM, gestational diabetes mellitus; SNP, single nucleotide polymorphism.